In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

My computer coding education ended in a high school classroom in the early 2000s, when I created a game in which two camels spit at one another. The experience of typing every line of code was ...